Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 71Nasopharyngeal Neoplasms 25Head and Neck Neoplasms 25Squamous Cell Carcinoma of Head and Neck 18Neoplasm Metastasis 14Carcinoma, Non-Small-Cell Lung 11Recurrence 9Salivary Gland Neoplasms 7Ovarian Neoplasms 7Stomach Neoplasms 6Pancreatic Neoplasms 6Small Cell Lung Carcinoma 5Prostatic Neoplasms 5Neoplasms 5Melanoma 5Colorectal Neoplasms 5Breast Neoplasms 5Triple Negative Breast Neoplasms 4Sarcoma 4Lung Neoplasms 4Esophageal Neoplasms 4Urinary Bladder Neoplasms 3Thyroid Neoplasms 3Laryngeal Diseases 3Epstein-Barr Virus Infections 3Colonic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Osteosarcoma 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2

Interventions

Cisplatin 2pembrolizumab 1nimotuzumab 1Re-Irradiation 1Gemcitabine 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Diseases × Gemcitabine × Head & Neck × Clear all
NCT03840421 2025-01-13

GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Active not recruiting
468 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡